No Data
Investing in Alimera Sciences (NASDAQ:ALIM) a Year Ago Would Have Delivered You a 68% Gain
Processa Pharmaceuticals Appoints Russell Skibsted as CFO
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Alimera Sciences, Inc. Buyout
Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8
Express News | Alimera Sciences Inc : Alliance Global Partners Cuts to Neutral From Buy
Craig-Hallum Upgrades Alimera Sciences(ALIM.US) to Buy Rating, Raises Target Price to $8
OneNightOnly : Could be. Let's see how market reacts later.
JC88 OP OneNightOnly : By the look of it, the volume is too low, if it can hit 6 bucks its already good lol